Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2600 of 3284 entries
View as:

Phase I Study to Assess the Effect of Food on AZD1775 Pharmacokinetics in Patients With Advanced Solid Tumours

Phase: N/A Priority: Normal
NCT ID: NCT03315091 Org: User:
Start: 09/29/17 End: 04/05/18 Due: 04/05/19

Study to Determine the Prevalence of Homologous Recombination Deficiency Among Women With Newly Diagnosed, High-grade, Serous or Endometrioid Ovarian, Primary Peritoneal, and/or Fallopian Tube Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04991051 Org: User:
Start: 05/02/21 End: 08/15/22 Due: 08/15/23

Assessment of the Safety and Pharmacokinetics of Single and Multiple Oral Doses of AZD4316 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01247103 Org: User:
Start: 12/31/10 End: 06/30/11 Due: 06/30/12

Long-term Follow-up of Antithrombotic Management Patterns in Acute Coronary Syndrome Patients in Russia

Phase: N/A Priority: Normal
NCT ID: NCT01373957 Org: User:
Start: 07/31/11 End: 03/31/14 Due: 03/31/15

A Study to Investigate the Effect of Food on Pharmacokinetics of Total EPA and Total DHA of AZD0585 in Healthy Male Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02372344 Org: User:
Start: 03/31/15 End: 05/31/15 Due: 05/31/16

A Global Study to Assess the Effects of MEDI4736 Following Concurrent Chemoradiation in Patients With Stage III Unresectable Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02125461 Org: User:
Start: 05/07/14 End: 08/24/23 Due: 08/24/24

AZD2423 Safety and Tolerability Study in Patients With Moderate and Severe Chronic Obstructive Pulmonary Disease(COPD)

Phase: N/A Priority: Normal
NCT ID: NCT01215279 Org: User:
Start: 10/31/10 End: 03/31/11 Due: 03/31/12

Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09)

Phase: N/A Priority: Normal
NCT ID: NCT04784715 Org: User:
Start: 04/26/21 End: 12/30/29 Due: 12/30/30

Multiple Ascending Doses (MAD) of AZD3199 Given Once Daily as Inhaled Formulation Via Turbuhaler to Healthy Men

Phase: N/A Priority: Normal
NCT ID: NCT00713271 Org: User:
Start: 08/31/08 End: 11/30/08 Due: 11/30/09

Anifrolumab Early Access Program

Phase: N/A Priority: Normal
NCT ID: NCT04750057 Org: User:
Start: - End: - Due: -

Evaluating a Novel Onco-genetic BRCA Testing Counselling Model Among Patients With Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02406235 Org: User:
Start: 04/21/15 End: 09/30/16 Due: 09/30/17

AZD1386 Japanese Multiple Ascending Dosing Study

Phase: N/A Priority: Normal
NCT ID: NCT00736658 Org: User:
Start: 06/30/08 End: 09/30/08 Due: 09/30/09

Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00108004 Org: User:
Start: 04/30/03 End: 06/30/05 Due: 06/30/06

Varicella Vaccination With Pulmicort

Phase: N/A Priority: Normal
NCT ID: NCT00641446 Org: User:
Start: 10/31/01 End: 10/31/03 Due: 10/31/04

Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD5055 in Japanese and Chinese Healthy Volunteers..

Phase: N/A Priority: Normal
NCT ID: NCT05955183 Org: User:
Start: 07/27/23 End: 12/04/23 Due: 12/04/24

A Study to Evaluate Safety and Tolerability After Oral Dosing of AZD1656 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00726427 Org: User:
Start: 07/31/08 End: 09/30/08 Due: 09/30/09

Post-Authorisation Safety Study of Lesinurad

Phase: N/A Priority: Normal
NCT ID: NCT04072471 Org: User:
Start: 01/29/21 End: 06/30/23 Due: 06/30/24

Gynecomastia Extension Study

Phase: N/A Priority: Normal
NCT ID: NCT00637182 Org: User:
Start: 01/31/01 End: 10/31/02 Due: 10/31/03

Study to Investigate Safety, Tolerability and Pharmacokinetics of AZD2423 Multiple Doses in Healthy Japanese Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01233830 Org: User:
Start: 11/30/10 End: 03/31/11 Due: 03/31/12

Cardiovascular Risk Stratification of Ambulatory Patients in Primary Prevention

Phase: N/A Priority: Normal
NCT ID: NCT01889030 Org: User:
Start: 07/31/13 End: 06/30/14 Due: 06/30/15

Forxiga Tablets Specific Clinical Experience Investigation for Long-term Use

Phase: N/A Priority: Normal
NCT ID: NCT02200666 Org: User:
Start: 10/03/14 End: 09/09/19 Due: 09/09/20

Casodex - Nolvadex Combination

Phase: N/A Priority: Normal
NCT ID: NCT00637871 Org: User:
Start: 11/30/02 End: 08/31/05 Due: 08/31/06

Seroquel Long-Term NIS for Schizophrenia Patients

Phase: N/A Priority: Normal
NCT ID: NCT00523783 Org: User:
Start: 05/31/07 End: 05/31/08 Due: 05/31/09

A Phase 3 Open-label Study to Evaluate the Safety of MEDI3250 in Healthy Japanese Children Age 2 Years Through 6 Years

Phase: N/A Priority: Normal
NCT ID: NCT02269488 Org: User:
Start: 11/30/14 End: 02/28/15 Due: 02/28/16

Esophageal Hypersensitivity Study in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00711048 Org: User:
Start: 06/30/08 End: 07/31/09 Due: 07/31/10